StockData
Intuitive Surgical Inc logo

Intuitive Surgical Inc (ISRG) stock

ISRGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 16/3030% above fair value
$430.53−7.22 (-1.65%)

Close on Nov 17, 2026Market cap $149.24BP/E 52.1Yield –

Intuitive Surgical r&d expenses

Research and development expenses are spending on new products and technology.

Intuitive Surgical's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.49B, up 19.2% year over year. For fiscal 2025 it was $1.31B, up 14.5% from the year before. Over ten years it grew 20.9% a year on average. The highest annual figure on record is $1.31B in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.31B+14.5%
FY2024Dec 31, 2024$1.15B+14.7%
FY2023Dec 31, 2023$998.80M+13.6%
FY2022Dec 31, 2022$879.00M+31.0%
FY2021Dec 31, 2021$671.00M+12.8%
FY2020Dec 31, 2020$595.10M+6.8%
FY2019Dec 31, 2019$557.30M+33.3%
FY2018Dec 31, 2018$418.10M+27.2%
FY2017Dec 31, 2017$328.60M+37.1%
FY2016Dec 31, 2016$239.60M+21.4%
FY2015Dec 31, 2015$197.40M+10.9%
FY2014Dec 31, 2014$178.00M+6.1%
FY2013Dec 31, 2013$167.70M-1.4%
FY2012Dec 31, 2012$170.00M+21.3%
FY2011Dec 31, 2011$140.20M+20.9%
FY2010Dec 31, 2010$116.00M+22.0%
FY2009Dec 31, 2009$95.10M+19.8%
FY2008Dec 31, 2008$79.40M+62.5%
FY2007Dec 31, 2007$48.86M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$408.30M+24.0%
Q2 FY2026Jun 30, 2026$370.60M+18.3%
Q1 FY2026Mar 31, 2026$361.90M+14.5%
Q4 FY2025Dec 31, 2025$352.90M+19.7%
Q3 FY2025Sep 30, 2025$329.40M+15.2%
Q2 FY2025Jun 30, 2025$313.30M+11.9%
Q1 FY2025Mar 31, 2025$316.20M+11.1%
Q4 FY2024Dec 31, 2024$294.70M+13.3%
Q3 FY2024Sep 30, 2024$286.00M+14.7%
Q2 FY2024Jun 30, 2024$280.10M+14.6%
Q1 FY2024Mar 31, 2024$284.50M+16.2%
Q4 FY2023Dec 31, 2023$260.10M+6.6%
Q3 FY2023Sep 30, 2023$249.40M+14.9%
Q2 FY2023Jun 30, 2023$244.40M+17.9%
Q1 FY2023Mar 31, 2023$244.90M+16.3%
Q4 FY2022Dec 31, 2022$244.10M+33.1%
Q3 FY2022Sep 30, 2022$217.10M+31.2%
Q2 FY2022Jun 30, 2022$207.30M+27.7%
Q1 FY2022Mar 31, 2022$210.50M+31.7%
Q4 FY2021Dec 31, 2021$183.40M+22.4%
Q3 FY2021Sep 30, 2021$165.50M+6.8%
Q2 FY2021Jun 30, 2021$162.30M+13.3%
Q1 FY2021Mar 31, 2021$159.80M+8.6%
Q4 FY2020Dec 31, 2020$149.80M-4.3%
Q3 FY2020Sep 30, 2020$155.00M+14.1%
Q2 FY2020Jun 30, 2020$143.20M+18.5%
Q1 FY2020Mar 31, 2020$147.10M+2.2%
Q4 FY2019Dec 31, 2019$156.60M+30.6%
Q3 FY2019Sep 30, 2019$135.90M+26.3%
Q2 FY2019Jun 30, 2019$120.80M+27.0%
Q1 FY2019Mar 31, 2019$144.00M+50.8%
Q4 FY2018Dec 31, 2018$119.90M+37.7%
Q3 FY2018Sep 30, 2018$107.60M+29.0%
Q2 FY2018Jun 30, 2018$95.10M+12.4%
Q1 FY2018Mar 31, 2018$95.50M+29.9%
Q4 FY2017Dec 31, 2017$87.10M+26.0%
Q3 FY2017Sep 30, 2017$83.40M–
Q2 FY2017Jun 30, 2017$84.60M–
Q1 FY2017Mar 31, 2017$73.50M–
Q4 FY2016Dec 31, 2016$69.10M–

More Intuitive Surgical figures

See a number that looks wrong?